A handful of biotech and pharmaceutical companies are kicking off earnings season this week, weaving Covid-19 updates into quarterly results tinged by the impact of a global pandemic. The virus continues to spread, with more than 3 million people worldwide now confirmed with the infection, as countries and U.S. states begin to ease lockdown restrictions.
This is CNBC’s live blog covering all…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.